Class information for:
Level 1: ADENOSINE A2A RECEPTOR//ADENOSINE A2A RECEPTORS//ISTRADEFYLLINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5261 1581 52.4 84%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1347 7852 ADENOSINE//ADENOSINE RECEPTORS//ADENOSINE A2A RECEPTOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ADENOSINE A2A RECEPTOR Author keyword 136 54% 11% 173
2 ADENOSINE A2A RECEPTORS Author keyword 48 58% 4% 56
3 ISTRADEFYLLINE Author keyword 37 81% 1% 22
4 A2A RECEPTOR Author keyword 29 44% 3% 51
5 ADENOSINE A2A RECEPTOR ANTAGONIST Author keyword 26 80% 1% 16
6 A2A ANTAGONIST Author keyword 21 75% 1% 15
7 RECEPTOR RECEPTOR INTERACTIONS Author keyword 21 61% 1% 22
8 A2A RECEPTORS Author keyword 21 48% 2% 31
9 KW 6002 Author keyword 19 76% 1% 13
10 A2A ANTAGONISTS Author keyword 19 71% 1% 15

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ADENOSINE A2A RECEPTOR 136 54% 11% 173 Search ADENOSINE+A2A+RECEPTOR Search ADENOSINE+A2A+RECEPTOR
2 ADENOSINE A2A RECEPTORS 48 58% 4% 56 Search ADENOSINE+A2A+RECEPTORS Search ADENOSINE+A2A+RECEPTORS
3 ISTRADEFYLLINE 37 81% 1% 22 Search ISTRADEFYLLINE Search ISTRADEFYLLINE
4 A2A RECEPTOR 29 44% 3% 51 Search A2A+RECEPTOR Search A2A+RECEPTOR
5 ADENOSINE A2A RECEPTOR ANTAGONIST 26 80% 1% 16 Search ADENOSINE+A2A+RECEPTOR+ANTAGONIST Search ADENOSINE+A2A+RECEPTOR+ANTAGONIST
6 A2A ANTAGONIST 21 75% 1% 15 Search A2A+ANTAGONIST Search A2A+ANTAGONIST
7 RECEPTOR RECEPTOR INTERACTIONS 21 61% 1% 22 Search RECEPTOR+RECEPTOR+INTERACTIONS Search RECEPTOR+RECEPTOR+INTERACTIONS
8 A2A RECEPTORS 21 48% 2% 31 Search A2A+RECEPTORS Search A2A+RECEPTORS
9 KW 6002 19 76% 1% 13 Search KW+6002 Search KW+6002
10 A2A ANTAGONISTS 19 71% 1% 15 Search A2A+ANTAGONISTS Search A2A+ANTAGONISTS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 KW 6002 65 93% 2% 25
2 A2A RECEPTORS 56 33% 9% 139
3 COTRANSFECTED FIBROBLAST CELLS 41 90% 1% 18
4 AGONIST H 3 CGS 21680 40 76% 2% 28
5 6 HYDROXYDOPAMINE LESIONED RATS 39 34% 6% 93
6 ADENOSINE A2A RECEPTORS 37 29% 7% 107
7 H 3 CGS 21680 33 56% 3% 40
8 INTEGRATIVE MECHANISM 30 84% 1% 16
9 DOPAMINE D 2 RECEPTORS 25 31% 4% 68
10 ISTRADEFYLLINE 21 73% 1% 16

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Adenosine A(2A) Receptor Antagonists in Parkinson's Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued 2014 11 74 78%
Targeting adenosine A(2A) receptors in Parkinson's disease 2006 181 71 87%
Adenosine, adenosine A(2A) antagonists, and Parkinson's disease 2009 93 88 69%
Adenosine A2A Antagonists in Parkinson's Disease: What's Next? 2012 24 64 80%
A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease 2015 1 13 62%
The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks 2015 2 99 32%
Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review 2014 13 86 42%
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia 1997 437 44 70%
GPCR Heteromers and their Allosteric Receptor-Receptor Interactions 2012 33 52 56%
An update on adenosine A(2A)-dopamine D-2 receptor interactions: Implications for the function of G protein-coupled receptors 2008 107 70 64%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CELLULAR MOL NEUROCHEM 9 31% 1.5% 24
2 PATOL TER EUT EXPT 9 26% 1.8% 29
3 NEUROSCI COIMBRA 7 21% 1.9% 30
4 SECT MOL NEUROPHARMACOL 7 32% 1.1% 17
5 ST PETERSBURG INFORMAT AUTOMAT 6 20% 1.7% 27
6 UNITAT FARMACOL 5 19% 1.6% 26
7 STUDIES PURINERG SYST 5 63% 0.3% 5
8 CENT NERVOUS SYST S 4 75% 0.2% 3
9 STRATEG PROD PORTFOLIO 4 75% 0.2% 3
10 PHARMA ZENTRUM BONN 4 40% 0.5% 8

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000259570 PROPENTOFYLLINE//ADENOSINE A1 RECEPTOR//A1 RECEPTOR
2 0.0000166628 MOL RECOGNIT SECT//A3 ADENOSINE RECEPTOR//ADENOSINE RECEPTORS
3 0.0000129328 ADENOSINE PHARMACOLOGY//ANESTHESIA VOLATILE ISOFLURANE NITROUS OXIDE//NBTI SENSITIVE ADENOSINE TRANSPORTER
4 0.0000127278 PHARMACOPERONE//MOL PHARMACOL GRP//BRET
5 0.0000117548 ENERGY DRINKS//CAFFEINE//ENERGY DRINK
6 0.0000067819 DARPP 32//PPP1R1B//ARPP 21
7 0.0000057254 NEW ENGLAND INFLAMMAT TISSUE PROTECT//MUCOSAL INFLAMMAT PROGRAM//ADENOSINE RECEPTORS
8 0.0000055986 PERINATAL NUTR METAB//SECT DEV ENDOCRINOL BIOLYALE CHILD HLTH CT//XENOBIOTIC AGENTS
9 0.0000051955 ABNORMAL PLASTICITY//EL MOUSE//EPILEPTIC MUTANT
10 0.0000046786 SKF83959//SKF 83959//TOPOGRAPHICAL ASSESSMENT